首页> 美国卫生研究院文献>Computational and Structural Biotechnology Journal >A Hybrid Computer-aided-diagnosis System for Prediction of Breast Cancer Recurrence (HPBCR) Using Optimized Ensemble Learning
【2h】

A Hybrid Computer-aided-diagnosis System for Prediction of Breast Cancer Recurrence (HPBCR) Using Optimized Ensemble Learning

机译:混合计算机辅助诊断系统用于通过优化的集成学习预测乳腺癌复发(HPBCR)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cancer is a collection of diseases that involves growing abnormal cells with the potential to invade or spread to the body. Breast cancer is the second leading cause of cancer death among women. A method for 5-year breast cancer recurrence prediction is presented in this manuscript. Clinicopathologic characteristics of 579 breast cancer patients (recurrence prevalence of 19.3%) were analyzed and discriminative features were selected using statistical feature selection methods. They were further refined by Particle Swarm Optimization (PSO) as the inputs of the classification system with ensemble learning (Bagged Decision Tree: BDT). The proper combination of selected categorical features and also the weight (importance) of the selected interval-measurement-scale features were identified by the PSO algorithm. The performance of HPBCR (hybrid predictor of breast cancer recurrence) was assessed using the holdout and 4-fold cross-validation. Three other classifiers namely as supported vector machines, DT, and multilayer perceptron neural network were used for comparison. The selected features were diagnosis age, tumor size, lymph node involvement ratio, number of involved axillary lymph nodes, progesterone receptor expression, having hormone therapy and type of surgery. The minimum sensitivity, specificity, precision and accuracy of HPBCR were 77%, 93%, 95% and 85%, respectively in the entire cross-validation folds and the hold-out test fold. HPBCR outperformed the other tested classifiers. It showed excellent agreement with the gold standard (i.e. the oncologist opinion after blood tumor marker and imaging tests, and tissue biopsy). This algorithm is thus a promising online tool for the prediction of breast cancer recurrence.
机译:癌症是一种疾病的集合,涉及不断增长的异常细胞的生长,这些细胞可能会侵入或扩散到人体。乳腺癌是女性癌症死亡的第二大主要原因。该手稿介绍了一种5年期乳腺癌复发预测方法。分析了579例乳腺癌患者的临床病理特征(复发率19.3%),并使用统计特征选择方法选择了鉴别特征。通过粒子群优化(PSO)对它们进行进一步完善,以作为具有集成学习功能的分类系统(袋式决策树:BDT)的输入。通过PSO算法确定了所选分类特征的适当组合以及所选间隔测量尺度特征的权重(重要性)。使用保留和4倍交叉验证评估HPBCR(乳腺癌复发的混合预测因子)的性能。比较了其他三个分类器,即支持向量机,DT和多层感知器神经网络。选择的特征是诊断年龄,肿瘤大小,淋巴结受累率,受累腋窝淋巴结数目,孕激素受体表达,激素治疗和手术类型。在整个交叉验证折叠和保留测试折叠中,HPBCR的最低灵敏度,特异性,精确度和准确性分别为77%,93%,95%和85%。 HPBCR优于其他经过测试的分类器。它显示了与黄金标准的极佳一致性(即血液肿瘤标记物和影像学检查以及组织活检后的肿瘤学家意见)。因此,该算法是用于预测乳腺癌复发的有前途的在线工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号